Campral
Formulated to target alcohol withdrawal symptoms to mitigate the urge to consume alcohol.
Strengths: 333mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Anti-alcohol preparation
- Pharmacological class
NMDA Receptor Modulator
- Contraindications
hypersensitivity to acamprosate; severe renal impairment
- Precautions and warnings
monitor for mood changes
- Minor side effects
diarrhoea; nausea; abdominal pain
- Moderate side effects
pruritus; skin rash
- Serious side effects
suicidal ideation — requires immediate medical attention
- Dosage forms
Gastro-resistant tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Merck Santé
- Onset Time
1 week
- Duration
12 months
- Storage instructions
Store in the original package below 30°C.
- Drug interactions
Alcohol
- Age restrictions
Not recommended for children or patients older than 65.
- Pregnancy and breastfeeding
Pregnancy: consult your doctor. Breastfeeding: use is generally not recommended.
Patient summary
Formulated to target alcohol withdrawal symptoms to mitigate the urge to consume alcohol.
Mechanism of action
The medication helps restore the balance between excitatory and inhibitory neurotransmitter systems in the brain, specifically affecting glutamate and GABA pathways, which are often disrupted by chronic alcohol consumption.
Campral
Formulated to target alcohol withdrawal symptoms to mitigate the urge to consume alcohol.
Editorial Notes
- Active ingredient(s): Acamprosate
- Listed indication(s): Alcohol Dependence
Available option
- 90 tablets - 333 mg1118-333-mg-14789